Hindalco Industries Regulatory Approval

Earnings Call

Hindalco Industries Earnings Call Transcript: Key Takeaways

Consolidated EBITDA ₹13,869 Cr (+52%) and PAT ₹7,534 Cr (+59%) led by India aluminium; copper includes ~₹350-400 Cr one-offs.

Financial Results

Hindalco Industries Q2 FY27 Results: Net Profit ₹7,533 Cr, Up 58.9% YoY

Hindalco Industries Ltd reported revenue from operations of ₹91,708 Cr (+38.8% YoY) and net profit of ₹7,533 Cr (+58.9% YoY) for Q2 FY27.

Key figure

Net profit ₹7,533 Cr · +58.9% YoY

Results Update

Hindalco Industries Results Update

Hindalco filed Novelis's Q2 FY27 news release and earnings presentation, released on the subsidiary's website. The release highlights net sales up 25% year-on-year.

Other Announcement

Hindalco Industries Other Announcement

SES ESG Research assigned Hindalco an ESG rating of 68. The company clarified it did not engage the rating agency; the report was independently prepared.

Other Announcement

Hindalco Industries Other Announcement

NSE Sustainability Ratings & Analytics Limited has assigned an ESG rating of 68 to Hindalco Industries Ltd, based on independently prepared information.

Merger & Restructuring

Hindalco Industries Merger & Restructuring

Hindalco Industries Ltd has terminated the Equity Purchase Agreement for the acquisition of AluChem Companies, Inc. due to extended closure delays.

Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity

9.42 MTPA

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.